組織蛋白酶D(CTSD)多克隆抗體
Polyclonal Antibody to Cathepsin D (CTSD)
CPSD; CLN10; Lysosomal Aspartyl Protease; Ceroid-Lipofuscinosis,Neuronal 10
- 編號UPAB280Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPB280Hu01-組織蛋白酶D(CTSD)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種-
- 應(yīng)用WB; IHC
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 299 ¥ 697 ¥ 996 ¥ 2490 ¥ 9960
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Ovary Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human CTSD Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Human Liver Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human CTSD Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;
Samples: Human Testis Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human CTSD Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;
Samples: Human Stomach Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human CTSD Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
DAB staining on IHC-P;
Samples: Human Pancreatic cancer Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human CTSD Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
WB圖
-
Western Blot; Sample: A431 cell lysate
Primary Ab: 0.2μg/ml Rabbit Anti-Human CTSD Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對CTSD的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CTSD。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPB280Hu61 | 組織蛋白酶D(CTSD)活性蛋白 | Cell?culture;?Activity?Assays. |
| UEPB280Hu61 | 組織蛋白酶D(CTSD)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB280Hu01 | 組織蛋白酶D(CTSD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UAPB280Hu62 | 組織蛋白酶D(CTSD)活性蛋白 | Cell?culture;?Activity?Assays. |
| UEPB280Hu62 | 組織蛋白酶D(CTSD)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB280Hu02 | 組織蛋白酶D(CTSD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB280Hu03 | 組織蛋白酶D(CTSD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPB280Hu04 | 組織蛋白酶D(CTSD)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB280Hu02 | 組織蛋白酶D(CTSD)多克隆抗體 | IHC; ICC/IF |
| UPAB280Hu01 | 組織蛋白酶D(CTSD)多克隆抗體 | WB; IHC |
| ULAB280Hu71 | 組織蛋白酶D(CTSD)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| UMAB280Hu21 | 組織蛋白酶D(CTSD)單克隆抗體 | ICC/IF |
| UMAB280Hu26 | 組織蛋白酶D(CTSD)單克隆抗體 | WB |
| UMAB280Hu22 | 組織蛋白酶D(CTSD)單克隆抗體 | WB; IHC; ICC/IF |
| UFAB280Hu02 | 抗組織蛋白酶D(CTSD)單克隆抗體 | Flow cytometry. |
| USEB280Hu | 組織蛋白酶D(CTSD)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| UHEB280Hu | 組織蛋白酶D(CTSD)檢測試劑盒(酶聯(lián)免疫吸附試驗法,高敏型) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMB280Hu | 組織蛋白酶D(CTSD)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Molecular Immunology | Cathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro [ScienceDirect: S0161589011008297] |
| 21 | Plasma Cathepsin D Levels: A Novel Tool to Predict Pediatric Hepatic Inflammation [PubMed: 25732418] |
| Scientific Reportes | Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention [pubmed:27922112] |
| Biomedicine & pharmacotherapy | Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms [pubmed:28061403] |
| JGH OPEN | Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis [] |
| Diabetologia | Plasma cathepsin D activity is negatively associated with hepatic insulin sensitivity in overweight and obese humans [Pubmed: 31690989] |
| Antioxidants | Iron and Advanced Glycation End Products: Emerging Role of Iron in Androgen Deficiency in Obesity [Pubmed: 32235809] |
| Peptides | LVV-hemorphin-7 (LVV-H7) plays a role in antinociception in a rat model of alcohol-induced pain disorders [33253777] |
| Cells | Identification of Cathepsin D as a Plasma Biomarker for Alzheimer's Disease [33445607] |
| J Chem Neuroanat | Analysis of silymarin-modulating effects against acrylamide-induced cerebellar damage in male rats: Biochemical and pathological markers [33965515] |
| Front Cell Infect Microbiol | PGRS Domain of Rv0297 of Mycobacterium tuberculosis Is Involved in Modulation of Macrophage Functions to Favor Bacterial Persistence [33042856] |
| Nutr Metab Cardiovasc Dis | Serum CathepsinD in pregnancy: relation with metabolic and inflammatory markers and effects of fish oils and probiotics [Pubmed:35304048] |
| Biosensors | A Comparison of Various Chips Used for the Manufacture of Biosensors Applied in Non-Fluidic Array SPRi, Based on the Example of Determination of Cathepsin D [Pubmed:35049649] |
留言咨詢
